VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients

Date
2008
Author
Ulutin, T.
Saip, S.
Ozgon, G. Oner
Siva, A.
Buyru, N.
Langaee, T. Y.
feng, h
Johnson, J. A.
Hatemi, A. C.
Metadata
Show full item record
Abstract
Objectives The objective of this study was to determine the quantitative influence of vitamin K epoxide reductase complex subunit 1 (VKORC1) and cytochrome P450 2C9 (CYP 2C9) polymorphisms on warfarin dose requirements in Turkish patients.
URI
http://hdl.handle.net/20.500.12627/137870
https://doi.org/10.1007/s00228-008-0507-5
Collections